Delivery Order SPE2DB22D3016-SPE2DB25FBJU5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Briviact 100 mg tablets (60-count packages) with a ceiling value of $1,067.55. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order valued at $7,488.40 to AmerisourceBergen Drug Corp for the supply of Briviact 50 mg tablets (60-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,804.93 to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Briviact 25 mg tablets in a quantity of 60 units, with a ceiling value of $3,121.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 18,...
- The Defense Logistics Agency awarded a $10,974.69 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is...
- The Defense Logistics Agency awarded a $3,168.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg, with an ultimate completion date of September 15, 2025. The award, issued on September 12, 2025, carries no set-aside designation and represents a competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a $5,572.14 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Briviact 100 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-unit package) under a firm fixed-price contract valued at $1,164.33. The order was competitively awarded without set-aside designation and is scheduled for completion by August 27, 2025. AmerisourceBergen will perform this work from its corporate office in Conshohocken, Pennsylvania, where the company is headquartered as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBJU5Delivery Order
The Defense Logistics Agency awarded a $7,166.00 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the federal government's military and veteran healthcare systems, supplying a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities through its extensive federal contract portfolio with DLA. This delivery order for Briviact, an antiepileptic medication, exemplifies the company's role in fulfilling the Defense Logistics Agency's pharmaceutical supply requirements across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 9/17/25 |